SETsquared Bristol’s Post

⚠️Last chance to book for our Healthtech Solutions panel event tomorrow, to discuss the challenge of developing and scaling healthtech products. Book now👉 https://brnw.ch/21wNyeE Whether you're pioneering customer-focused biotech, advancing enterprise software, or pushing the boundaries of clinical diagnostic hardware, the path to market in the healthtech sector remains a unique and evolving challenge for every founder.🛣️ Healthtech innovation comes with challenges that traditional startup methods and regulations can't fully address. Healthtech development is complex, involving a mix of hardware, software, and strict regulatory requirements that require a more specialised approach.🩺 This event is designed to strengthen the growing local healthtech community. It’s an excellent opportunity to learn and network, so book now!🤝 https://brnw.ch/21wNyeE Chair: Paul Forster, Incubation Manager - SETsquared Bristol Panellists: Jenny Bailey Cooper, CEO - Ferryx Jenny Button, CEO - Emm Joshua Steer, CEO - Radii Devices Michael Roberts, CEO - GenomeKey 📅 9 October 🕚 2.30 - 4.30 pm 📍 Engine Shed, Bristol This event is proudly part of Bristol Tech Festival. #Startups #Founders #Incubator #Accelerator #Healthtech #Digitalhealth #Biotech #Medtech

▶️Co11ab is thrilled to partner and shoutout on A*StartCentral Elevate HealthTech US Program. 5 out 12 startups are co11ab members: Carecam, Cogniant, Health BETA, iota medtech, and Kinexcs. Their journey and achievements are truly inspiring! ▶️This success highlights the importance of global partnerships, particularly started between Cedars-Sinai Technology Ventures, A*STAR - Agency for Science, Technology and Research and A*StartCentral. These collaborations have significantly enhanced market access to the US, providing our startups with invaluable opportunities for growth and expansion. 🍾🍾Congratulations to all the teams for their dedication and hard work. We look forward to seeing your continued success! ✨ About co11ab ✨ At co11ab, we are dedicated to empowering innovation and catalyzing impactful change in the biomedtech industry. Our vibrant ecosystem provides startups with the resources, mentorship, and global networks necessary to thrive. Join us and become part of a community that is driving the future of healthcare! #StartupSuccess #GlobalPartnership #Innovation #MarketAccess

Hey everyone, have you heard the news? The MedTech Innovator Accelerator just announced its 2024 cohort, and it's a game-changer! With 65 startups at the forefront of medical innovation, we're looking at some seriously exciting developments in the world of healthcare. This year's cohort is incredibly diverse, covering everything from diagnostics and digital health to medical devices. These startups are tackling some of the most pressing healthcare challenges today, and I can't wait to see the impact they'll make. The selection process was no joke - only the most promising and impactful startups made the cut. Now, they'll have access to resources, mentorship, and industry connections that can supercharge their growth and bring their innovations to market more quickly. It's beyond thrilling to see so many creative solutions emerging to improve patient care and outcomes. The MedTech Innovator Accelerator continues to be a critical platform for fostering innovation in the healthcare industry, and I couldn't be more excited about what's to come. I'm genuinely looking forward to seeing how these startups will shape the future of medtech and contribute to better health solutions globally. The future of medical technology is looking brighter than ever, and I'm here for it! https://lnkd.in/guzPcjbg

Your startup wants to improve tomorrow's #healthcare? Then apply now for batch no. 9 of the #4CAccelerator and learn how to overcome the challenges of this complex industry and how to successfully bring your product to market! Who can apply? 💡 MedTech startups with pre-competitive product ideas in the fields of hashtag#MedicalDevices, hashtag#DigitalHealth and hashtag#InVitroDiagnostics can apply until January 17, 2025. What awaits you? 🚀 #4CWorkshops by the Stiftung für Medizininnovationen In 15 interactive workshops together with top experts, you will gain a deep understanding of the 4Cs and be trained in the “4C Business Modelling” method. 💪 #4CCoaching by the MII team After successful workshop participation, our coaches, Ingo, Henrike, Christian and Ramona, will accompany you for another 6 months in implementing your milestones. 💙 #4CCommunity You will become part of our vibrant MedTech community and get access to exclusive networking events and peer formats. What is the goal? ✅ Our program will enable you to develop an entrepreneurially successful AND regulatory plausible business model for the healthcare industry. You will become #InvestorReady! Find more information and the application form on our website 👉 https://lnkd.in/eiENYKDS hashtag#startupbw hashtag#startupbwaccelerator

How to Identify Disruptive Healthtech Startups! Investing in healthtech is about identifying startups that can truly disrupt the status quo. Start by analyzing the problem they aim to solve—is it a significant healthcare challenge, like chronic disease management or diagnostic delays? Look for clinical validation, such as pilot studies or partnerships with hospitals, which indicate credibility. Assess the team’s expertise, particularly founders with backgrounds in both healthcare and technology. The startup’s scalability matters, so examine their ability to expand operations or adapt to new markets. Don’t overlook regulatory readiness—are they prepared to meet HIPAA, FDA, or EU standards? Lastly, explore their traction: customer interest, pre-orders, or early revenue streams signal market demand. What’s the most important factor you consider in healthtech investments?

It’s a wrap! The 2024 edition of the MedTech Strategist Innovation Summit in Dublin is in the books.🍀 It was a pleasure to (re)connect with MedTech start-ups and investors. Great to have three Brightlands Venture Partners portfolio companies in attendance: Hy2Care® BV, TripleMed and the latest member of the BVP family (soon to be announced! 😎 ). My 5 key take-aways of the summit: 1. The MedTech field keeps producing innovative solutions that will significantly enhance treatment outcomes in a cost-effective manner. MedTech therefore remains a key pillar for future-proofing our healthcare systems. 2. Strategics are acquiring MedTech start-ups later and later, often necessitating start-ups to go commercial stage themselves. Hence, having a strategy from the get-go to work towards a self-sustaining company post-regulatory clearance is increasingly critical for start-ups. 3. In reaction to strategics acquiring MedTech start-ups later, larger VCs are generally also moving to later stages for their initial investments. This is slowly but surely starting to lead to a valley of death at the earlier stages. 4. Start-ups and investors jointly need to ensure capital efficiency and realistic valuations at early stages, as otherwise the math won’t work at later deal stages (typically leading to later-stage investors not willing to engage at all 😟). 5. Reimbursement and Regulatory are not the same. MedTech start-ups were historically laser-focused on obtaining regulatory clearance. However, given that start-ups might have to go commercial prior to acquisition nowadays, understanding what it takes to achieve reimbursement is as important as understanding the regulatory pathway. Thanks for hosting this incredible event MedTech Strategist. Looking forward to next years edition! 

Public Exits Are Getting More Feasible In The Medtech Space – MedCity News - MedCity News #PublicExits #MedTech #Feasibility Public Exits Are Getting More Feasible In The Medtech Space A recent trend in the healthcare IT industry is the increasing feasibility of public exits for companies in the medtech space. This trend is driven by various factors such as capital availability and market demand. #MarketTrends #InvestmentOpportunities Market Trends and Investment Opportunities With the rise of digital health technologies, there is a growing demand for innovative solutions in the healthcare industry. This has created new investment opportunities for companies in the medtech sector looking to go public. #RegulatoryEnvironment #Compliance Navigating the Regulatory Environment and Ensuring Compliance One of the key challenges for medtech companies seeking ai.mediformatica.com #medtech #startups #this #report #pitchbook #cost #healthcare #medcity #news #outdated #digitalhealth #healthit #healthtech #healthcaretechnology @MediFormatica (https://buff.ly/3MdOLkZ)

👉 Convergence Partners × Tech4Eva - The global Femtech accelerator × Women's Health Startups | Investor Matchmaking Roadshow on Oct. 10 🌱 What to Know: ↗️ The global Femtech market size was estimated at USD 33.92 billion in 2023 and is expected to grow at a CAGR of 16.30% from 2024 to 2030 (Grand View Research). ↗️ The growth of the industry is expected to be driven by several key factors such as increased adoption of digital health solutions, among others. Don’t miss this exclusive opportunity to connect with the future of innovation. ↗️ 💡 Start-ups pitching include: Babyndex, Calico Biosystems, Fetosense® by CareNX, CC Diagnostics, Cosm Medical, DeepLook Medical, EndoCure Ltd., Galena Innovations, Harmonia Healthcare, Herosupport SA, hormona, Mamotest, Namida Lab, Inc. Sin Reglas, Vital Start Health, and VivoSensMedical GmbH ↗️ Investors will have the opportunity to engage in a Q&A session with the Founders and explore innovative investment opportunities. 📈 We are thrilled to have our mentor investors moderating the sessions: - Yahel Halamish from Nina Capital - Dominnique Karetsos from Amboy Street Ventures - Daniel Koppelkamm, CFA from Convergence Partners 🔗 Register now: https://lnkd.in/eqf5-7n9 Partners: EPFL Innovation Park, Groupe Mutuel, BioAlps - Swiss Health Valley, Business Angels Switzerland, DayOne - Healthcare Innovation  , Embassy of Switzerland in the United Kingdom, Essity, FemTech Analytics, Femtech France, fermata, Inc., INSEAD Healthcare Club, Joyance Partners, Gesundheitsförderung Schweiz, RH Capital, SICTIC, Swiss Biotech Association, Swissnex in Boston and New York, Women of Wearables (wearables, health tech & femtech) #epflinnovationpark #groupemutuel #Femtech #womenshealthmatters #WomensHealth #Innovation #Healthtech #Venturecapital #Investors #Startups #BusinessAngels

🚀 Are you working on innovative solutions in #Medtech, #Healthtech, #DigitalHealth, or #Pharma? Do you want to make a real impact on human well-being and tackle genuine clinical challenges? Welcome to Health Design 2024 – a pitch competition where innovation meets real-world needs! 🚀 🔬 You have a couple more days until September 27th to apply for a chance to showcase your solution live at Aalto University on October 15th-16th. The competition is open to Nordic and Baltic #startups and #university spinouts taking their first steps toward success. 🌍 Why Participate? ➡ Gain visibility with leading Nordic/Baltic Angels & VCs ➡ Present solutions that address real patient and clinician needs ➡ Compete for opportunities to start investment discussions and scale your venture Whether you’re a university spinout or a #startup with humble beginnings, if your solution is scalable and impactful, this is your moment! Read more and apply now: https://lnkd.in/dQn6heDR #HealthDesign #StartupCompetition #NordicInnovation #BalticInnovation Business Helsinki Terkko Health Hub Health Capital Helsinki

Hello, dear friends! Recent healthtech funding rounds show the sector is heating up, but challenges remain: ❇️ Transform Health raised $111M, surpassing its initial target and eyeing more healthtech startups. ❇️ UK-based Signify Research Ltd secured £6M to expand its healthtech market intelligence services globally. ❇️ Rotterdam's Kaminari Medical bagged €3.8M to accelerate development of its intravascular imaging technology. ❇️ US-based Suki raised a massive $70M Series D to expand its AI voice solutions for healthcare. What's driving these trends? 💡 Sector-specific strength: Healthtech and fintech remain top-funded sectors in the UK. 🌍 Global interest: 70% of VC investments in UK startups came from abroad in 2024. 🏥 Focus on innovation: Funds are targeting companies with modern solutions serving vulnerable populations. 🤖 AI integration: Companies leveraging AI for healthcare are attracting significant investment. 🔬 Specialized tech: Startups with niche offerings like intravascular imaging are finding eager investors. 📊 Market intelligence: Investors value data-driven insights in the healthtech space. What can healthtech startups learn? 🎯 Target real problems: Investors are looking for solutions that address critical health needs. 🌐 Think global: International investors are hungry for UK healthtech innovations. 🤝 Embrace partnerships: Many successful rounds involve multiple types of investors, from VCs to philanthropic organizations. 📈 Prove your impact: Demonstrating real-world results and scalability is key to attracting investment. From proving your concept and UVP to developing just the right features to satisfy your users and catch the interest of VCs, DM me for a little (or bigger) help from Softvery Solutions:) What's your take on the current healthtech funding landscape? Share your thoughts in the comments! #HealthTech #StartupFunding #VentureCapital #MedTech #AIinHealthcare #DigitalHealth #Innovation #Future #DigitalHealth #AI